Evidence map›Paper›PMID 32206660›Full record

ArticleObstetrics & gynecology science2020

Oxaloacetate reduces emotional symptoms in premenstrual syndrome (PMS): results of a placebo-controlled, cross-over clinical trial.

Lisa Tully, John Humiston, Alan Cash

2 registry-linked trialsOpen access · diamondAbstract read
In one paragraph

Article in Obstetrics & gynecology science, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
2.3field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03509714 nacompletednot on this map

Oxaloacetate Supplementation for Emotional PMS; Measuring Improvements in Depression, Anxiety, Perceived Stress, and Aggression

TypeinterventionalSponsorTerra Biological LLCRan2016 to 2017Enrolled48ConditionsPremenstrual Syndrome (PMS)ArmsJubilance (100 mg Oxaloacetate/150 mg Ascorbic Acid), rice flour (Placebo)
NCT05273372 nacompletednot on this mapstarted 2022, after this paper: background citation

A Randomized Double Blind Placebo Controlled Trial to Determine the Effects of Oxaloacetate on Improving Fatigue in ME/CFS

TypeinterventionalSponsorTerra Biological LLCRan2022 to 2024Enrolled82ConditionsMyalgic Encephalomyelitis, Chronic Fatigue Syndrome, FatigueArmsPlacebo, Medical Food - Anhydrous Enol-Oxaloacetate
3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 15 citations in OpenAlex.

  1. Lactate: A Theranostic Biomarker for Metabolic Psychiatry?Antioxidants (Basel, Switzerland) · 2023
    Review
  2. Review
  3. Review
  4. Review
  5. Management of Premenstrual Dysphoric Disorder: A Scoping Review.International journal of women's health · 2022
    Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Lisa TullyNutritional Supplements Division, Energy Medicine Research Institute, Boulder, CO, USA.
John HumistonThe Center for Health and Wellbeing, San Diego, CA, USA.
Alan CashTerra Biological LLC, San Diego, CA, USA.ORCID https://orcid.org/0000-0003-1916-960X
US Biologic (United States) · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivePremenstrual syndrome (PMS) affects millions of women. While over-the-counter products have helped with the physical symptoms of PMS, emotional symptoms have been less well supported. The objective of this trial was to measure the effect of an oxaloacetate/vitamin C combination on the major emotional symptoms of PMS, including depression, anxiety, perceived stress, aggression, and suicidal ideation.

methodsForty-eight women experiencing PMS completed a baseline survey comprising the Beck's Depression Inventory, Cohen Perceived Stress Scale, Generalized Anxiety Disorder Test, and Buss-Perry Aggression Questionnaire. After baseline measurements, participants were randomly assigned to take either 2 capsules of 100 mg oxaloacetate/150 mg ascorbic acid, or 2 capsules of rice flour (placebo) for their entire menstrual cycle. At menstruation, the women completed the 4 surveys again. The women then switched capsules in a cross-over design and continued the study for an additional menstrual cycle. The final assessment was repeated at menstruation. Statistical analysis of the 4 surveys was performed to examine efficacy.

resultsOxaloacetate/vitamin C supplementation during PMS significantly improved depression, perceived stress, anxiety, aggression, and suicidal ideation. The mean improvement in depression was 54.1%, 35.8% for perceived stress, 51.43% for generalized anxiety, and 17.8% for aggression. Suicidal ideation was reduced by 47.9%. All results were highly significant.

conclusionA combination of oxaloacetate and vitamin C supplementation helped to alleviate depression, anxiety, perceived stress, aggression, and suicidal ideation symptoms associated with PMS.

trial registrationClinicalTrials.gov Identifier: NCT03509714.

Indexed as

AnxietyDepressionOxaloacetatePremenstrual syndromeSuicidal ideation

Identifiers

PMID32206660
PMCPMC7073356
OpenAlexW3011874045

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.